## ALB: Albemarle Corporation - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_20 at 5.2% in lower entry zone (4.0-10.0%), top quartile (87th pct) cross-sectional ranking. Short-term MRS_5 (1.6%) confirms momentum alignment. Outperforming sector by 2.0%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($135.22)
- **If Wrong:** Exit if MRS_20 drops below entry zone or breaks stop
- **Invalidation:** MRS_20 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 4, Bearish: 1)

**1. Albemarle (ALB) Valuation Check After Bullish Analyst Upgrades on Lithium Demand and Supply Deficit Themes**
- Source: Simply Wall Street | 20260105T034357 | Somewhat-Bullish | Relevance: 100%
- Albemarle (ALB) has seen a surge in investor interest and share price due to bullish analyst upgrades on lithium demand and expected supply deficits. Despite significant recent gains and trading above some analyst targets, a "most popular narrative" suggests Albemarle is currently overvalued, with a fair value estimate of around $107 per share against its closing price of $143.93. The article advises investors to assess if the current market price reflects genuine mispricing or if the future growth is already priced in, while also noting risks such as prolonged oversupply or policy shifts affecting EV demand.

**2. Investors Buy Large Volume of Call Options on Albemarle (NYSE:ALB)**
- Source: MarketBeat | 20260105T175344 | Bullish | Relevance: 100%
- Investors have purchased a significantly higher volume of call options on Albemarle (NYSE:ALB), showing increased bullish sentiment. This unusual activity, 177% above the typical daily volume, comes amidst mixed analyst ratings and a recent beat on EPS expectations. Despite some upgrades, the consensus analyst rating for ALB remains "Hold" with a price target of $120.83, while the stock trades near its one-year high.

**3. Stanley Laman Group Ltd. Takes Position in Albemarle Corporation $ALB**
- Source: MarketBeat | 20260105T121002 | Somewhat-Bullish | Relevance: 100%
- Stanley Laman Group Ltd. has acquired a new position in Albemarle Corporation (NYSE:ALB), purchasing 41,850 shares valued at approximately $3.39 million during the third quarter. While analysts offer mixed ratings, with UBS upgrading Albemarle to a "buy," the MarketBeat consensus remains a "Hold" with a target price of $120.21. Albemarle recently surpassed Q3 earnings estimates and paid a quarterly dividend of $0.405 per share.

**4. Jefferies raises Albemarle stock price target to $167 on lithium demand outlook**
- Source: Investing.com India | 20260105T102352 | Bullish | Relevance: 100%
- Jefferies has increased its price target for Albemarle (NYSE:ALB) to $167.00 from $152.00, maintaining a Buy rating due to the anticipated impact of widespread robotics adoption on chemical markets and subsequent lithium demand. The new target suggests a 16% upside, and the company has shown strong price return momentum in the past six months. Other firms like Morgan Stanley and Truist Securities have also adjusted their ratings and price targets for Albemarle, reflecting optimism about increased demand and improving lithium prices.

**5. Jefferies raises Albemarle stock price target to $167 on lithium demand outlook**
- Source: Investing.com UK | 20260105T101600 | Bullish | Relevance: 100%
- Jefferies has increased its price target for Albemarle (NYSE:ALB) to $167.00 from $152.00, maintaining a Buy rating due to an optimistic lithium demand outlook, particularly driven by "mobile physical AI" and widespread robotics adoption. This revised target implies a 16% upside, even as the stock trades near its 52-week high. While Jefferies is bullish, InvestingPro's Fair Value model suggests the stock may be slightly overvalued, though analysts hold a moderate buy consensus.

### Analyst Activity

**Target Signal:** VERY_BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-19 | Wells Fargo | $135 | $100 | +35% |
| 2025-12-18 | Citigroup | $150 | $100 | +50% |
| 2025-12-18 | Mizuho | $132 | $110 | +20% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-19 | Wells Fargo | main | Equal-Weight |
| 2025-12-18 | Citigroup | main | Neutral |
| 2025-12-18 | Mizuho | main | Neutral |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 4 ($0.65M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 46.9% |
| Smart Money | **BEARISH** |
| Net Flow | 0.0% |
| Buying/Selling | 4 / 6 |

**Top Holders:**
- Vanguard Group Inc: 12.4% (-0.8%)
- Capital World Invest: 7.0% (+0.2%)
- Blackrock Inc.: 7.0% (-0.1%)
- State Street Corpora: 4.8% (-15.4%)
- Franklin Resources, : 2.8% (-42.8%)

### Key Risks

1. Valuation stretched: PEG 19.6x requires aggressive growth execution.
2. Elevated short interest (12.5%): bears positioning against stock.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +35%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 19.64 signals overvaluation risk, limited margin of safety. Balance sheet: strong liquidity (2.3x). Analyst sentiment positive (3 raises, avg +35%). Institutional flow bearish (6 selling vs 4 buying).

| Metric | Value |
|--------|-------|
| Market Cap | $17.2B |
| Beta | 1.41 |
| 52W Range | $49.43 - $152.08 |
| Short Interest | 12.5% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 19.64 |
| Forward P/E | 135.1 |
| Current P/E | N/A |
| YoY Growth | N/A |
| EPS Direction | None |

### Technicals

MRS_20 deteriorating from 6.7% to 5.2% (-1.4% in 5 days), indicating relative weakness vs NASDAQ. Currently in lower STRENGTH zone (4.0-10.0%), cross-sectional ranking at 87th percentile. MRS_5 at 1.6% confirms short-term momentum alignment. AM_20 at 5.4% shows strong absolute momentum above own 20MA. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram bearish (-0.72), momentum weakening. OFD pattern: -DUN (Resistance).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | 5.23% (CS: 88) | Strong |
| RSI_14 | 65.8 | Neutral |
| MACD Histogram | -0.72 | Bearish |
| vs SMA20 | 1.053x | Above |
| vs SMA50 | 1.202x | Above |
| vs SMA200 | 1.744x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $146.12
- **Stop Loss:** $135.22 (7.5% risk)
- **Target:** $162.47 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 126
- **Position Value:** $18,411.12
- **Portfolio %:** 18.41%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | MOMENTUM (Zone F) | 1.20x |

*NORMAL regime with moderate risk appetite. VIX remains calm at 14.9 (8th percentile) with positive yield curve (+65bps) and healthy breadth (59.2%), though elevated put/call ratio (1.27) suggests institutional hedging despite surface calm. Focus on quality with awareness of hedging activity divergence.*

### Earnings

**Next:** 2026-02-11 (Est: $-0.67)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $-0.88 | $-0.19 | +78.3% |
| 2025Q2 | $-0.81 | $0.11 | +113.5% |
| 2025Q1 | $-0.68 | $-0.18 | +73.5% |
| 2024Q4 | $-0.67 | $-1.09 | -63.0% |

---
*RULE-based L3 | 2026-01-07 09:36 | MRS_20*